AQST
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Aquestive Therapeutics resubmitted its NDA to the FDA for Anaphylm (dibutepinephrine) sublingual filmSep 17, 2026
- Aquestive Therapeutics announced positive topline human factors and pharmacokinetic results for Anaphylm sublingual filmAug 10, 2026
- A lawsuit alleged that Aquestive Therapeutics concealed deficiencies in its Anaphylm NDAApr 17, 2026
- Aquestive Therapeutics received FDA Complete Response Letter for AnaphylmFeb 2, 2026
- Aquestive Therapeutics announces FDA will not require advisory committee meeting to discuss new drug application for Anaphylm™Sep 4, 2025